A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age. Επικοινωνία Submitted by Εμμανουήλ Ροηλίδης on Παρ, 11/13/2020 - 09:55
